Navigation Links
Sigma-Aldrich Announces New Prestige Antibodies(TM) Line for Proteomics and Cell Biology Researchers
Date:2/14/2008

Sigma-Aldrich and Atlas Antibodies Establish Exclusive Distribution

Partnership

ST. LOUIS, Feb. 14 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL) today announced an exclusive partnership with Atlas Antibodies to distribute Prestige Antibodies(TM) -- developed by the Human Proteome Resource -- to the proteomics and cell biology research communities. Initially consisting of 1800 antibodies, the library is expected to grow by several thousand per year with the goal of producing at least one antibody to all 22,000 non-redundant human proteins by 2015. Through this partnership, Sigma-Aldrich is granted exclusive distribution rights in the U.S. and all regions outside of Europe, with co-exclusive distribution rights in Europe.

Prestige Antibodies(TM) are highly characterized and offer significant value to the research community. Each antibody is highly validated for specificity and accompanied by over 500 immunohistochemical images, which are displayed in the publicly accessible Human Protein Atlas. In addition, Prestige Antibodies(TM) are optimized on a single protocol and tailored for high throughput operations, providing significant time and cost savings for researchers. The antibodies are designed to have low cross-reactivity to other human proteins and to work in a variety of applications and tissue preparations. All Prestige Antibodies(TM) are tested in multiple assurance steps to ensure that they are the most specific products on the market.

"We are delighted to have been chosen as the exclusive distributor of Prestige Antibodies(TM), and we expect to release substantial additions to the catalog annually," said Dr. David Smoller, President of Sigma-Aldrich's Research Biotech business unit. "By making these high quality and highly validated antibodies accessible to proteomics and cell biology researchers worldwide, Sigma-Aldrich is helping to further promote the study of disease."

Atlas Ant
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
2. Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies
3. Sigma-Aldrich Expansion in Republic of China to Support SAFC Growth
4. Sigma-Aldrich and Ingenuity Systems Announce Partnership to Create E-Commerce Search Solution Based on Biological Knowledge
5. Sigma-Aldrich to Present at the UBS 2007 Global Life Sciences Conference on September 25, 2007
6. Sigma-Aldrich Names Patrick Sullivan New VP of Research and Development for Research Biotech
7. Sigma-Aldrich and the Universite de Montreal Establish Collaboration for RNA Interference Studies
8. Sigma-Aldrich Corporations 3rd Quarter 2007 Earnings Conference Call
9. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
10. Sigma-Aldrich (Nasdaq: SIAL) Q3 2007 Sales Increase 14.0%, Yielding Diluted EPS of $.54.
11. Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22, 2015 Shimadzu Scientific Instruments ... multipurpose UV-visible spectrophotometer. Offering wavelength scanning from 190 ... ideal for applications in a variety of industries, ... The user-friendly UV-1280 enables intuitive operation, while the ...
(Date:1/22/2015)... The laboratory information management systems market is ... of technological advancements due to factors such as rising ... integrate healthcare systems, and increasing government support for adoption ... Key players in the market focus on technological advancements ...
(Date:1/22/2015)... Dr. Greg Leyer of UAS Labs recently was invited to ... on probiotics in San Diego, CA. , The Scripps ... health care professionals. This year’s pre-conference seminar was held on ... Dr. Leyer spoke about the emerging topics and science in ...
(Date:1/22/2015)... , Jan. 22, 2015   Cypher Genomics, ... Sequenom, Inc. (NASDAQ: SQNM ), the ... agreement for next generation noninvasive prenatal tests (NIPT). ... interpretation technology, called Mantis™, to advance analysis of ...
Breaking Biology Technology:Shimadzu’s New Monitored Single-Beam UV-Vis Spectrophotometer Offers Comprehensive Measurement Options in a Compact Body 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 4Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4
... May 12 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) announced ... present at the Rodman & Renshaw Annual Global Investment Conference taking place in ... , , ... Summer Time ( 5:15 a.m. Eastern Daylight Time ) on Tuesday, May ...
... May 12 /PRNewswire-FirstCall/ - Aeterna Zentaris Inc. ... drug development company specialized in oncology and endocrine ... Drug Administration (FDA) has approved the Company,s Investigational ... conjugate compound, AEZS-108, in luteinizing hormone releasing hormone ...
... 2010 , , , ... New Outcomes Trial to Expand Evidence for Dronedarone in a Different AF,Population , ... Sanofi-aventis (EURONEXT: SAN and NYSE: ... to assess the potential clinical benefit of Multaq(R) (dronedarone),in over 10, 000 patients with ...
Cached Biology Technology:Aeterna Zentaris: FDA Approves Investigational New Drug (IND) Application for Doxorubicin Targeted Conjugate Compound, AEZS-108, in Bladder Cancer 2Aeterna Zentaris: FDA Approves Investigational New Drug (IND) Application for Doxorubicin Targeted Conjugate Compound, AEZS-108, in Bladder Cancer 3Sanofi-aventis Initiates 10,000 Patient Study With Multaq(R) in Permanent AF 2Sanofi-aventis Initiates 10,000 Patient Study With Multaq(R) in Permanent AF 3Sanofi-aventis Initiates 10,000 Patient Study With Multaq(R) in Permanent AF 4Sanofi-aventis Initiates 10,000 Patient Study With Multaq(R) in Permanent AF 5Sanofi-aventis Initiates 10,000 Patient Study With Multaq(R) in Permanent AF 6Sanofi-aventis Initiates 10,000 Patient Study With Multaq(R) in Permanent AF 7Sanofi-aventis Initiates 10,000 Patient Study With Multaq(R) in Permanent AF 8Sanofi-aventis Initiates 10,000 Patient Study With Multaq(R) in Permanent AF 9Sanofi-aventis Initiates 10,000 Patient Study With Multaq(R) in Permanent AF 10
(Date:12/24/2014)...  Since its launch in December 2014, the 1U™ ... of trying to remember their usernames and passwords through replacing ... smartphones. To assist people who have struggled to remember usernames ... 1U and focuses on redefining identity, announced today that it ...
(Date:12/22/2014)... Dec. 22, 2014 Research and Markets ... the "The Global Watermarking and Fingerprinting Markets" ... http://photos.prnewswire.com/prnh/20130307/600769 This insight ... watermarking and fingerprinting markets. Watermarking aims to control ...
(Date:12/19/2014)... and Markets ( http://www.researchandmarkets.com/research/8kmfcn/iphone_5s ) has announced ... - Apple/AuthenTec TMDR92 & Sapphire - Technology Report" ... http://photos.prnewswire.com/prnh/20130307/600769 Following the acquisition of AuthenTec ... with the iPhone 5S. It is currently the only ...
Breaking Biology News(10 mins):1U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3The Global Watermarking and Fingerprinting Markets 2iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2
... biofuel? Now that a University of Illinois metabolic engineer has ... of fermenting galactose, the answer is an unequivocal yes. ... miscanthus, and switchgrass. ln small island or peninsular nations, though, ... a U of I assistant professor of microbial genomics and ...
... found a key to keeping stem cells in their neutral ... published in the journal PLoS One , the researchers ... soft gel rather than on a hard plate or dish ... the ability to become any type of tissue. The soft ...
... 15, 2010 For Immediate Release The Scripps ... (UCSD) School of Medicine have been awarded approximately $7.5 ... could eventually become drug candidates for the treatment of ... funds awarded, $5 million will go to Scripps Research, ...
Cached Biology News:Seaweed as biofuel? Metabolic engineering makes it a viable option 2Soft substrate promotes pluripotent stem cell culture 2Soft substrate promotes pluripotent stem cell culture 3Team awarded $7.5 million to identify potential drug candidates to treat nicotine addiction 2Team awarded $7.5 million to identify potential drug candidates to treat nicotine addiction 3
JTV1 gene...
APO-BrdU™ TUNEL Assay Kit *with Alexa Fluor® 488 anti-BrdU* *60 assays*...
The FlowTACS Apoptosis Detection Kit is designed specifically for in situdetection of apoptotic...
Recombinant Rat PTX2/SAP...
Biology Products: